What’s different about GovTech?
Nick Bowden

Substitute HealthTech for GovTech and the article is equally applicable. Particularly this sentence, “ … to replace something in the budget, the bar for product viability isn’t minimally-viable.” That’s something investors, who rightly know there’s a real opportunity in these complex spaces, but have traditional B2B or consumer experience, really don’t understand. It can take years to get to product market fit. And when you do, the barriers to entry for the competition are extreme.

Like what you read? Give Matthew Amsden a round of applause.

From a quick cheer to a standing ovation, clap to show how much you enjoyed this story.